Ponatinib as second-line treatment in Chronic Myeloid Leukemia
Latest Information Update: 11 Sep 2018
At a glance
- Drugs Ponatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 11 Sep 2018 New trial record
- 01 Sep 2018 Results published in the Annals of Hematology